Reporting & Principles

We work to create advances in healthcare through pioneering research and global development, manufacturing and commercial capabilities, and upholding our commitment to ethical conduct and overall corporate responsibility.

This commitment is grounded in our Code of Business Conduct, which applies to all employees, agents and consultants acting on behalf of Biogen. We also are guided by a range of principles, policies and positions, and other statements on ethical business conduct, compliance, accountability and transparency, among other topics, including:

Transparency in Reporting

Biogen is committed to meeting its global transparency reporting requirements. We believe transparency is an important part of our ongoing collaboration with the healthcare community, helping to build a community of trust and respect with healthcare professionals, patients, industry peers, stockholders and the public.


Patient Safety

Patient safety is our highest priority and we are committed to complete and timely evaluation of the benefits and risks of our therapies and to communicating this information to help patients and healthcare professionals make informed treatment decisions. We take seriously our ethical and regulatory responsibility to continually assess and communicate the benefits and risks of our products and investigational therapies to patients, healthcare professionals and regulators.

Biogen-225548 | Date of preparation: December 2023